Arcturus Therapeutics Holdings Inc (ARCT)
16.91
-0.16
(-0.94%)
USD |
NASDAQ |
Nov 22, 16:00
16.94
+0.03
(+0.18%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Revenue (TTM): 142.47M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 142.47M |
| June 30, 2024 | 147.03M |
| March 31, 2024 | 110.62M |
| December 31, 2023 | 157.75M |
| September 30, 2023 | 292.72M |
| June 30, 2023 | 262.71M |
| March 31, 2023 | 280.24M |
| December 31, 2022 | 205.76M |
| September 30, 2022 | 51.50M |
| June 30, 2022 | 40.57M |
| March 31, 2022 | 15.48M |
| December 31, 2021 | 12.36M |
| September 30, 2021 | 8.803M |
| June 30, 2021 | 8.699M |
| Date | Value |
|---|---|
| March 31, 2021 | 9.02M |
| December 31, 2020 | 9.539M |
| September 30, 2020 | 10.27M |
| June 30, 2020 | 11.25M |
| March 31, 2020 | 19.08M |
| December 31, 2019 | 20.79M |
| September 30, 2019 | 25.40M |
| June 30, 2019 | 25.50M |
| March 31, 2019 | 17.74M |
| December 31, 2018 | 15.75M |
| September 30, 2018 | 10.20M |
| June 30, 2018 | 10.07M |
| March 31, 2018 | 11.44M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
8.699M
Minimum
Jun 2021
292.72M
Maximum
Sep 2023
90.83M
Average
30.68M
Median
Revenue (TTM) Benchmarks
| Bioventus Inc | 555.06M |
| Fulcrum Therapeutics Inc | -- |
| Pfizer Inc | 59.37B |
| AIM ImmunoTech Inc | 0.19M |
| Protalix BioTherapeutics Inc | 45.67M |